0

AMD3465

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP185991075
CAS185991-07-5
Molecular Weight896.07
Description≥98% (HPLC)
SolubilityH2O: 25 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to light brown
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

64 Cu-{ N-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine}

Kam Leung

PMID: 22206104

1

CXCR4 Antagonism in Combination With IDO1 Inhibition Weakens Immune Suppression and Inhibits Tumor Growth in Mouse Breast Cancer Bone Metastases

Jian Zhang, Yanxia Pang, Tao Xie, Liulong Zhu

Onco Targets Ther. 2019 Jun 28;12:4985-4992.

PMID: 31388305

1

Development of a novel 99m Tc-labeled small molecular antagonist for CXCR4 positive tumor imaging

Xuran Zhang, Linyi You, Shuting Chen, Mengna Gao, Zhide Guo, Jin Du, Jie Lu, Xianzhong Zhang

J Labelled Comp Radiopharm. 2018 May 15;61(5):438-446.

PMID: 29370457

1

N-[ 11 C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs

S V Hartimath, M A Khayum, A van Waarde, R A J O Dierckx, E F J de Vries

Mol Imaging Biol. 2017 Aug;19(4):570-577.

PMID: 27896627

1

Suppression of the SDF‑1/CXCR4/β‑catenin Axis Contributes to Bladder Cancer Cell Growth Inhibition in Vitro and in Vivo

Tao Zhang, Fei Yang, Wenbiao Li, Bolong Liu, Wende Li, Zhiyi Chen, Can Wang

Oncol Rep. 2018 Sep;40(3):1666-1674.

PMID: 30015971

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode